Special Report

Special Report Jason Mast and Adam Feuerstein

STAT Plus: A bellwether moment: Once a distant dream, gene therapy for Duchenne nears historic decision

Special Report Jonathan Wosen

STAT Plus: Research misconduct allegations put Stanford’s president — and science — under an uncomfortable spotlight

Special Report Brittany Trang

STAT Plus: As AI promises to revolutionize medical note-taking, concerns mount about accuracy and harm

Special Report Lev Facher

STAT Plus: How the drug industry uses fear of fentanyl to extract more profit from naloxone

The Obesity Revolution Elaine Chen and Matthew Herper

STAT Plus: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Special Report Jason Mast, Allison DeAngelis, and Megan Molteni

STAT Plus: CRISPR patent fight redux? A new battle is brewing among biotechs over next-gen gene-editing tools

Special Report Mohana Ravindranath

STAT Plus: How Mindstrong’s rush to roll out a ‘smoke alarm’ for mental illness led to its downfall

Special Report Rosa Furneaux and Laura Margottini — TBIJ

STAT Plus: The drug was meant to save children’s lives. Instead, they’re dying

Special Report Jason Mast

STAT Plus: We finally have new drugs for sickle cell disease. Why are so few patients taking them?

Special Report Rachel Cohrs Zhang

STAT Plus: PhRMA, once invincible in Washington, has lost its edge

Special Report Jonathan Wosen

STAT Plus: ‘The tipping point is coming’: Unprecedented exodus of young life scientists is shaking up academia

Special Report Casey Ross

Microsoft’s note-taking tool asks doctors to make a grand bargain: Share patient data, and get your life back

Special Report Matthew Herper

Here’s why we’re not prepared for the next wave of biotech innovation

Special Report Tara Bannow and Bob Herman

STAT Plus: Private equity’s Welsh Carson, casting itself as a noble force, relentlessly pursues profits in health care

Special Report Karen Pennar

‘If I were a hospital, I’d be reading the tea leaves’: Pressures grow on the health care industry to reduce its climate pollution

Special Report Casey Ross

STAT Plus: Epic’s overhaul of a flawed algorithm shows why AI oversight is a life-or-death issue

Special Report Sarah Owermohle

STAT Plus: A minuscule new HHS office has a mammoth goal: tackling environmental justice

Special Report Casey Ross and Mohana Ravindranath

STAT Plus: Minimal compliance, or meaningful change? Epic faces a crossroads as new rules put pressure on health data sharing

Special Report Olivia Goldhill

STAT Plus: Tobacco giant Philip Morris is investing billions in health care. Critics say it’s peddling cures for its own poison

Special Report Usha Lee McFarling

‘So much more to do’: A hospital system’s campaign to confront racism — and resistance to change — makes early strides

Special Report Andrew Joseph

Two deadly days in St. Louis: An overdose cluster kills 8 Black people — and shows the new shape of the addiction crisis

Special Report Bob Herman, Kate Sheridan, J. Emory Parker, Adam Feuerstein, and Mohana Ravindranath

Health care’s high rollers: As the pandemic raged, CEOs’ earnings surged

Special Report Eric Boodman

In the label ‘adult failure to thrive,’ medicine reveals its own failures

Special Report Angus Chen

This clinical trial wanted to end breast cancer disparities. But first it needed to enroll Black women

Special Report Andrew Joseph

To protect people with addiction from discrimination, the Justice Dept. turns to a long-overlooked tool: the ADA

Special Report Todd Feathers, Simon Fondrie-Teitler, Angie Waller, and Surya Mattu — The Markup

STAT Plus: Facebook is receiving sensitive medical information from hospital websites

Special Report Angus Chen

STAT Plus: ‘How do you decide?’: Cancer treatment’s CAR-T crisis has patients dying on a waitlist

Special Report Jonathan Moens

Costly Alzheimer’s treatment is spreading around the world, with virtually no science to back it up

Special Report Megan Molteni

STAT Plus: From burst bubble to medical marvel: How lipid nanoparticles became the future of gene therapy